SCHEMBL901448

SCHEMBL901448

C#CCNC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL11505943 0.89 ALOX15 (0.43)
SCHEMBL12148789 0.74
SCHEMBL5534526 0.72
SCHEMBL5061919 0.72
SCHEMBL560841 0.72
SCHEMBL2900032 0.72
SCHEMBL9083515 0.72 TAS2R38 (0.33)
SCHEMBL20694367 0.70
SCHEMBL6475871 0.70
SCHEMBL5264057 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3492477-B1 BORON-CONTAINING COMPOUND STELLA PHARMA CORP (JP) 2023-09-06 EP claimed
EP-3358346-B1 ENANTIOMER ANALYSIS METHOD AJINOMOTO KK (JP) 2022-01-19 EP claimed
CN-108743969-B Preparation method of tumor targeting nano-carrier with cell-like cell-penetrating peptide function 合肥工业大学 2021-09-07 CN claimed
CN-109762142-B Conjugated polymer material for regulating and controlling carbon dioxide adsorption based on photothermal effect 河北工业大学 2021-05-11 CN claimed
EP-3194030-B1 SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV NEW YORK BLOOD CENTER INC (US) 2019-11-06 EP claimed
EP-3219335-B1 COATING COMPOSITION AND MEDICAL DEVICE TERUMO CORP (JP) 2018-12-19 EP claimed
EP-2513113-B1 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS IDENIX PHARMACEUTICALS LLC (US) 2018-08-01 EP claimed
EP-2476691-B1 METHOD FOR MANUFACTURING A LIPIDIC PEPTIDE COMPOUND NISSAN CHEMICAL IND LTD (JP) 2018-01-03 EP claimed
EP-2813250-B1 COATING COMPOSITION AND MEDICAL DEVICE TERUMO CORP (JP) 2017-05-03 EP claimed
EP-2801379-B1 COATING COMPOSITION AND MEDICAL DEVICE TERUMO CORP (JP) 2017-03-08 EP claimed
EP-0435059-B1 Retroviral protease inhibitors HOECHST AG (DE) 1997-11-05 EP claimed
EP-0687251-A1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI (FR) 1995-12-20 EP claimed
WO-1995018105-A1 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3 BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCINE AGONISTS AND/OR ANTAGONISTS SANOFI (FR) 1995-07-06 WO claimed
EP-0410278-B1 Renin inhibiting aminooligohydroxy-derivatives HOECHST AG (DE) 1994-01-19 EP claimed
EP-0376899-B1 USE OF L-CARNITINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE THERAPEUTICAL TREATMENT OF PERIPHERAL NEUROPATHIES Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1993-08-04 EP claimed
EP-0293881-B1 PEPTIDE BORONIC ACID INHIBITORS OF TRYPSIN-LIKE PROTEASES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-03-10 EP claimed
EP-0350422-B1 PROPARGYLGUANIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF LABORATORIOS VINAS S.A. (ES) 1992-09-16 EP claimed
EP-0252030-B1 DERIVATIVES OF L-AMINO ACYL L-CARNITINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS HAVING HEPATOPROTECTING ACTIVITY CONTAINING SAME Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1992-06-17 EP claimed
EP-0350422-A1 Propargylguanidine derivatives and process for the preparation thereof LABORATORIOS VINAS S.A. (ES) 1990-01-10 EP claimed
EP-0077460-B1 PURINE COMPOUNDS ENDOWED WITH IMMUNOMODULATING ACTIVITY CO PHARMA CORPORATION S.r.l. (IT) 1986-10-15 EP claimed